PLx Pharma Winddown Corp. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/eedc19d1-fa51-4b0c-a824-e38920966c78/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-46.1M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-005920 |
| FY 2020 | $-15.2M | 2020-01-01 – 2020-12-31 | evidence 0001437749-22-005920 |
| FY 2019 | $-20.5M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-005044 |
| FY 2018 | $896.5k | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-004386 |
| FY 2017 | $-15.3M | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-005277 |
| FY 2016 | $-4.9M | 2016-01-01 – 2016-12-31 | evidence 0001437749-18-005277 |
| FY 2015 | $-18.7M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-011428 |
| FY 2014 | $-13.6M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002607 |
| FY 2013 | $-11.3M | 2010-01-14 – 2014-03-31 | evidence 0001104659-14-037539 |
| FY 2012 | $-1.8M | 2012-01-01 – 2012-12-31 | evidence 0001104659-14-037539 |
| FY 2011 | $-2.0M | 2011-01-01 – 2011-12-31 | evidence 0001104659-14-037539 |
| FY 2010 | $-915.7k | 2010-01-14 – 2010-12-31 | evidence 0001104659-14-037539 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PLx Pharma Winddown Corp. — all facts · Revenue · Operating Income